| Literature DB >> 25165825 |
Dorte H Højland1, Karl-Martin Vagn Jensen1, Michael Kristensen1.
Abstract
BACKGROUND: Spinosad is important in pest management strategies of multiple insect pests. However, spinosad resistance is emerging in various pest species. Resistance has in some species been associated with alterations of the target-site receptor, but in others P450s seems to be involved. We test the possible importance of nine cytochrome P450 genes in the spinosad-resistant housefly strain 791spin and investigate the influence of spinosad on P450 expression in four other housefly strains.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25165825 PMCID: PMC4148238 DOI: 10.1371/journal.pone.0103689
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Constitutive and spinosad induced P450 gene expression of a spinosad-susceptible housefly strain (WHO-SRS) and spinosad -resistant housefly strain (791spin) measured by quantitative real-time PCR.
| Strain | Gene | Male | Female | Constitutive | Spinosad | ||||||
| Constitutive | Spinosad | Fold- change | P-value | Constitutive | Spinosad | Fold- change | P-value | P-value | P-value | ||
|
|
| 947±517 | 1,810±611 | 0.1014 | 2,540±1,858 | 16,680±508 | 6.6 |
| 0.1797 |
| |
|
| 8.9±4.3 | 25.9±3.1 | 2.9 |
| 1.9±1.2 | 3.2±0.3 | 1.7 |
|
|
| |
|
| 6.2±1.1 | 7.2±1.8 | 0.3829 | 3.9±1.8 | 8.4±5.0 | 0.0593 | 0.0734 | 0.8665 | |||
|
| 118±44.9 | 310±22.9 | 2.6 |
| 53.3±5.2 | 141±18.1 | 2.6 |
|
|
| |
|
| 1,090±331 | 1,730±1007 | 0.9999 | 284±58.3 | 1,320±174 | 4.7 |
|
| 0.9999 | ||
|
| 69.4±11.0 | 206±45.9 | 3.0 |
| 13.5±4.7 | 57.9±19.7 | 4.3 |
|
|
| |
|
| 154±35.5 | 394±128 | 2.6 |
| 50.8±22.9 | 348±133 | 6.9 |
|
| 0.4318 | |
|
| 21.6±10.2 | 12.7±9.8 | 0.1807 | 7.0±0.8 | 13.2±1.8 | 1.9 |
|
| 0.9452 | ||
|
| 36.4±7.5 | 41.5±5.5 | 0.2786 | 10.9±3.6 | 22.5±5.0 | 2.1 |
|
|
| ||
|
| 4,860±680 | 8,570±1508 | 1.8 |
| 4,550±319 | 8,700±676 | 1.9 |
| 0.5358 | 0.3829 | |
|
|
| 2,100±497 | 1,010±318 | 0.5 |
| 11,790±7106 | 7,800±2400 | 0.6943 |
|
| |
|
| 24.3±8.8 | 42.0±14.4 | 1.7 |
| 6.2±4.0 | 6.8±3.6 | 0.5358 |
|
| ||
|
| 2.4±0.7 | 3.8±1.1 | 0.3717 | 0.8±0.5 | 3.2±0.7 | 4.0 |
|
| 0.8745 | ||
|
| 327±71.7 | 288±19.7 | 0.9 |
| 166±77.1 | 128±14.1 | 0.9999 |
|
| ||
|
| 797±144 | 599±274 | 0.2359 | 662±569 | 472±57 | 0.7104 | 0.6806 | 0.9999 | |||
|
| 405±49.8 | 467±83.5 | 0.2198 | 51.5±28.1 | 428±191 | 8.3 |
|
| 0.9372 | ||
|
| 363±95.5 | 513±223 | 0.3148 | 756±413 | 485±36.1 | 0.7012 | 0.2222 | 0.7104 | |||
|
| 200±48.2 | 305±21.1 | 1.5 |
| 66.4±30.6 | 224±53.9 | 3.4 |
|
|
| |
|
| 26.3±6.0 | 33.2±3.0 | 1.3 |
| 18.0±12.0 | 16.7±4.2 | 0.9452 | 0.2561 |
| ||
|
| 6,610±162 | 5,810±1238 | 0.1871 | 6,750±1089 | 5,670±721 | 0.1812 | 0.3984 | 0.7206 | |||
Mean mRNA transcript copy number×1000 is per 20 ng of total RNA. P-values between comparisons of male and female flies and treatment were obtained by a F-test followed by Student’s Significant difference t-Test. Significant P-values (<0.05) are underlined.
P-values obtained by comparisons of constitutive and spinosad induced gene expression within strain.
P-values obtained by comparisons of gene expression between sexes.
P450 gene expression of insecticide-susceptible and -resistant housefly strains upon sugar (constitutive) and spinosad exposure measured by quantitative real-time PCR.
| Gene | Strain | Male | Female | ||||||
| Constitutive | Spinosad | Fold- change | P-value | Constitutive | Spinosad | Fold- change | P-value | ||
|
| WHO-SRS | 8.9±4.3 | 25.9±3.1 | 2.9 |
| 1.9±1.2 | 3.2±0.3 | 1.7 |
|
| 766b | 15.6±8.9 | 33.5±11.5 | 2.1 |
| 8.7±0.6 | 8.7±1.1 | 0.8357 | ||
| 791a | 0.8±0.4 | 0.6±0.3 | 0.3939 | 0.6±0.3 | 0.7±0.2 | 0.5622 | |||
| 845b | 55.4±23.6 | 49.6±19.9 | 0.8075 | 25.9±10.4 | 10.9±5.0 | 0.4 |
| ||
|
| WHO-SRS | 6.2±1.1 | 7.2±1.8 | 0.3829 | 3.9±1.8 | 8.4±5.0 | 0.0593 | ||
| 766b | 15.1±5.8 | 21.2±5.3 | 0.0721 | 11.5±5.3 | 11.4±3.0 | 0.6126 | |||
| 791a | 148±92.2 | 188±38.3 | 0.4452 | 101±58.2 | 48.9±8.9 | 0.2949 | |||
| 845b | 34.4±22.3 | 48.7±15.8 | 0.5362 | 46.3±22.9 | 53.4±16.2 | 0.4385 | |||
|
| WHO-SRS | 118±44.9 | 310±22.9 | 2.6 |
| 53.3±5.2 | 141±18.1 | 2.6 |
|
| 766b | 199±110 | 283±70.8 | 0.3374 | 95.1±27.1 | 114±46.4 | 0.9015 | |||
| 791a | 101±72.7 | 130±18.5 | 0.9452 | 45.8±29.2 | 35.6±14.9 | 0.5287 | |||
| 845b | 202±48.5 | 254±68.9 | 0.1042 | 156±36.5 | 218±54.3 | 0.1321 | |||
|
| WHO-SRS | 1,090±331 | 1,730±1,010 | 0.9999 | 284±58.3 | 1,320±174 | 4.7 |
| |
| 766b | 3,480±660 | 5,810±1,110 | 1.7 |
| 1670±250 | 1,990±519 | 0.3439 | ||
| 791a | 4,010±2,652 | 3,910±570 | 0.9999 | 2,040±1,320 | 1,190±607 | 0.2380 | |||
| 845b | 2,360±1,029 | 1,910±289 | 0.6503 | 1,030±312 | 1,480±849 | 0.5787 | |||
|
| WHO-SRS | 69.4±11.0 | 206±45.9 | 3.0 |
| 13.5±4.7 | 57.9±19.7 | 4.3 |
|
| 766b | 1,220±441 | 2,020±477 | 0.0649 | 495±79.8 | 645±38.2 | 1.3 |
| ||
| 791a | 214±154 | 249±61.1 | 0.9999 | 122±94.6 | 30.4±12.8 | 0.6691 | |||
| 845b | 846±612 | 448±143 | 0.6718 | 426±107 | 436±65.2 | 0.7345 | |||
|
| WHO-SRS | 154±35.5 | 394±128 | 2.6 |
| 50.8±22.9 | 348±133 | 6.9 |
|
| 766b | 1,060±246 | 2,220±293 | 2.1 |
| 783±120 | 378±141 | 0.5887 | ||
| 791a | 157±130 | 339±161 | 0.1014 | 177±160 | 58.3±41.3 | 0.5338 | |||
| 845b | 1,070±762 | 685±416 | 0.3845 | 519±323 | 893±488 | 0.2561 | |||
|
| WHO-SRS | 21.6±10.2 | 12.7±9.8 | 0.1807 | 7.0±0.8 | 13.2±1.8 | 1.9 |
| |
| 766b | 63.2±19.5 | 129.1±33.6 | 2.0 |
| 58.9±11.1 | 59.9±9.8 | 0.9551 | ||
| 791a | 64.8±7.7 | 73.0±23.2 | 0.7789 | 45.8±15.5 | 29.6±3.9 | 0.1003 | |||
| 845b | 69.7±30.9 | 38.9±16.0 | 0.1014 | 34.9±14.3 | 62.8±24.0 | 1.8 |
| ||
|
| WHO-SRS | 36.4±7.5 | 41.5±5.5 | 0.2786 | 10.9±3.6 | 22.5±5.0 | 2.1 |
| |
| 766b | 124±43.9 | 344±119 | 2.8 |
| 65.5±8.3 | 313±96.2 | 4.8 |
| |
| 791a | 83.7±10.8 | 65.8±7.9 | 0.8 |
| 34.3±13.3 | 29.2±8.9 | 0.8286 | ||
| 845b | 110±56.7 | 99.3±20.5 | 0.9551 | 50.0±22.3 | 87.2±44.5 | 0.1893 | |||
|
| WHO-SRS | 947±517 | 1,810±611 | 0.1014 | 2,540±1,860 | 16,680±508 | 6.6 |
| |
| 766b | 10,550±1,444 | 17,190±4,200 | 1.6 |
| 15,040±1,830 | 21,450±2,390 | 1.4 |
| |
| 791a | 12,770±671 | 5,520±725 | 0.4 |
| 18,960±9,490 | 6,440±1,630 | 0.3 |
| |
| 845b | 3,660±2,659 | 4,640±1,500 | 0.4598 | 7,900±4,000 | 9,530±1,910 | 0.1589 | |||
|
| WHO-SRS | 4,860±680 | 8,570±1,510 | 1.8 |
| 4,550±319 | 8,700±676 | 1.9 |
|
| 766b | 9,550±662 | 10,930±3,680 | 0.9999 | 7,460±546 | 7,430±1,060 | 0.6126 | |||
| 791a | 11,430±4,981 | 10,820±1,120 | 0.7012 | 10,140±4,210 | 7,060±1,320 | 0.9999 | |||
| 845b | 3,780±918 | 4,670±1,220 | 0.1673 | 4,560±1,060 | 5,090±534 | 0.1501 | |||
Mean mRNA transcript copy number×1000 is per 20 ng of total RNA. P-values between comparisons of treatments were obtained by a F-test for determination of variance differences followed by Welch Significant difference Test. Significant P-values (<0.05) are underlined.
P-values obtained by comparisons of constitutive and spinosad induced gene expression within strain.
Figure 1WHO-SRS male (A) and female (B) spinosad-influenced gene expression as a function of the constitutive gene expression.
The line represents no effect of spinosad exposure. Genes in right-lower and left-upper corner are down-regulated and up-regulated by spinosad, respectively. Points marked with * are significantly different from the separation line by α = 0.05.
Figure 2791spin male (A) and female (B) spinosad-influenced gene expression as a function of the constitutive gene expression.
The line represents no effect of spinosad exposure. Genes in right-lower and left-upper corner are down-regulated and up-regulated by spinosad, respectively. Points marked with * are significantly different from the separation line by α = 0.05.